Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Surface Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Venrock Healthcare Capital Partners II, L.P. | 1,442,895 3.500% |
-2,435,000 (-62.79%) |
Filing |
| 2020-05-29 4:05 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
Venrock Healthcare Capital Partners II, L.P. | 3,877,895 9.900% |
3,877,895 (New Position) |
Filing |